Rosoxacin

From Wikipedia, the free encyclopedia

Rosoxacin
Systematic (IUPAC) name
1-Ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid
Identifiers
CAS number 40034-42-2
ATC code J01MB01
PubChem 287180
Chemical data
Formula C17H14N2O3 
Mol. mass 294.30 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Rosoxacin (also known as acrosoxacin, tradename Eradacil) is a quinolone antibiotic indicated for the treatment of urinary tract infections and certain sexually transmitted diseases. Rosoxacin is not available in the United States.

It was developed by Sanofi-Synthelabo (now part of sanofi-aventis).